SCHEMBL8556849

SCHEMBL8556849

CCOC(=O)CNC(C)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.48
MGAM O43451 1/20 0.48
SI P14410 1/20 0.48
MGAM2 Q2M2H8 1/20 0.48
ALDH1A1 P00352 4/20 0.40
TRPA1 O75762 1/20 0.40
PPID Q08752 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 1/20 0.38
EGLN1 Q9GZT9 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11193578 0.86 GAA (0.50) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL15971334 0.82 GAA (0.50) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL452234 0.81 GAA (0.54) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL641811 0.81 TSHR (0.40) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL641810 0.81 TSHR (0.40) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL11288753 0.81 GAA (0.45) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL2903501 0.81 GAA (0.45) GAAMGAMSIMGAM2ALDH1A1
Hydrochloric Acid SCHEMBL28584781 0.79 GAA (0.43) GAAMGAMSIMGAM2ALDH1A1
SCHEMBL2909142 0.79 ALDH1A1 (0.47) GAAMGAMSIMGAM2ALDH1A1
Hydrochloric Acid SCHEMBL29798612 0.79 GAA (0.43) GAAMGAMSIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2594557-A1 Substituted aminopropionic derivatives as neprilysin inhibitors Novartis AG (CH) 2013-05-22 EP disclosed
EP-2594556-A1 Substituted aminopropionic derivatives as neprilysin inhibitors Novartis AG (CH) 2013-05-22 EP disclosed
WO-2012065958-A1 METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY NOVARTIS AG (CH) 2012-05-24 WO disclosed